{"disease":{"id":"recipients-of-liver-transplant","name":"recipients of liver transplant"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03828058","title":"Envarsus XL Immunosuppression Following Liver Transplantation","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":110,"lead_sponsor_name":"Methodist Healthcare","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}